Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neva Caliskan

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Nature Communications|October 12, 2019
Thermodynamic control of -1 programmed ribosomal frameshiftingLars V Bock, Neva Caliskan, Natalia Korniy, et al.
Nucleic Acids Research|December 20, 2022
Cis-mediated interactions of the SARS-CoV-2 frameshift RNA alter its conformations and affect functionLukas Pekarek, Matthias M Zimmer, Anne-Sophie Gribling-Burrer, et al.
Nature Structural & Molecular Biology|March 22, 2016
Choreography of molecular movements during ribosome progression along mRNARiccardo Belardinelli, Heena Sharma, Neva Caliskan, et al.
Nature Communications|December 10, 2021
Structural and molecular basis for Cardiovirus 2A protein as a viral gene expression switchChris H Hill, Lukas Pekarek, Sawsan Napthine, et al.
Molecular Cell|February 18, 2025
AcrVIB1 inhibits CRISPR-Cas13b immunity by promoting unproductive crRNA binding accessible to RNase attackKatharina G Wandera, Stefan Schmelz, Angela Migur, et al.
Nature Communications|December 11, 2021
The short isoform of the host antiviral protein ZAP acts as an inhibitor of SARS-CoV-2 programmed ribosomal frameshiftingMatthias M Zimmer, Anuja Kibe, Ulfert Rand, et al.
Nucleic Acids Research|November 9, 2021
Investigating molecular mechanisms of 2A-stimulated ribosomal pausing and frameshifting in TheilovirusChris H Hill, Georgia M Cook, Sawsan Napthine, et al.
Microbiology Spectrum|June 21, 2023
Mouse Liver-Expressed Shiftless Is an Evolutionarily Conserved Antiviral Effector Restricting Human and Murine HepacivirusesYudi Zhang, Volker Kinast, Julie Sheldon, et al.
Nucleic Acids Research|December 19, 2025
Type I-Fv and engineered type IV-A1 CRISPR-Cas effectors facilitate genome reduction in Escherichia coliNathalie Klein, Mariana Sanchez-Londono, Meral M Kara, et al.
Molecular Pharmaceutics|February 14, 2025
Designing the <i>Aplysia punctata</i> Arginine-Depleting Enzyme for Tumor TargetingAlena Maria Wolkersdorfer, Yuri Endo, Josef Kehrein, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Nature Communications|October 12, 2019
Thermodynamic control of -1 programmed ribosomal frameshiftingLars V Bock, Neva Caliskan, Natalia Korniy, et al.
Nucleic Acids Research|December 20, 2022
Cis-mediated interactions of the SARS-CoV-2 frameshift RNA alter its conformations and affect functionLukas Pekarek, Matthias M Zimmer, Anne-Sophie Gribling-Burrer, et al.
Nature Structural & Molecular Biology|March 22, 2016
Choreography of molecular movements during ribosome progression along mRNARiccardo Belardinelli, Heena Sharma, Neva Caliskan, et al.
Nature Communications|December 10, 2021
Structural and molecular basis for Cardiovirus 2A protein as a viral gene expression switchChris H Hill, Lukas Pekarek, Sawsan Napthine, et al.
Molecular Cell|February 18, 2025
AcrVIB1 inhibits CRISPR-Cas13b immunity by promoting unproductive crRNA binding accessible to RNase attackKatharina G Wandera, Stefan Schmelz, Angela Migur, et al.
Nature Communications|December 11, 2021
The short isoform of the host antiviral protein ZAP acts as an inhibitor of SARS-CoV-2 programmed ribosomal frameshiftingMatthias M Zimmer, Anuja Kibe, Ulfert Rand, et al.
Nucleic Acids Research|November 9, 2021
Investigating molecular mechanisms of 2A-stimulated ribosomal pausing and frameshifting in TheilovirusChris H Hill, Georgia M Cook, Sawsan Napthine, et al.
Microbiology Spectrum|June 21, 2023
Mouse Liver-Expressed Shiftless Is an Evolutionarily Conserved Antiviral Effector Restricting Human and Murine HepacivirusesYudi Zhang, Volker Kinast, Julie Sheldon, et al.
Nucleic Acids Research|December 19, 2025
Type I-Fv and engineered type IV-A1 CRISPR-Cas effectors facilitate genome reduction in Escherichia coliNathalie Klein, Mariana Sanchez-Londono, Meral M Kara, et al.
Molecular Pharmaceutics|February 14, 2025
Designing the <i>Aplysia punctata</i> Arginine-Depleting Enzyme for Tumor TargetingAlena Maria Wolkersdorfer, Yuri Endo, Josef Kehrein, et al.
Pageof 4